Home » Healthcare » Endoluminal Suturing Device Market

Endoluminal Suturing Device Market By Product (Endovascular Suturing Devices, Endoscopic Suturing Devices, Consumables); By Application (Urological Procedures, Thoracic Procedures, Gastrointestinal Procedures, Other Procedures); By End User (Specialty Clinics, Independent Surgical Centers, Hospitals, Ambulatory Surgical Centers) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4699

Published: | Report ID: 73039 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Endoluminal Suturing Device Market Size 2024  USD 106.9 Million
Endoluminal Suturing Device Market, CAGR  12.5%
Endoluminal Suturing Device Market Size 2032  USD 274.28 Million

Market Overview:

The Endoluminal Suturing Device Market is projected to grow from USD 106.9 million in 2024 to USD 274.28 million by 2032, at a CAGR of 12.5% from 2024 to 2032.

The primary drivers of the endoluminal suturing device market include the increasing demand for minimally invasive surgeries, as they offer numerous benefits such as reduced recovery times, less pain, and minimal scarring compared to traditional surgical approaches. This trend is particularly evident in fields like gastroenterology and urology, where endoluminal procedures are becoming the standard. Additionally, the growing aging population, particularly in developed countries, is driving the need for complex surgeries, further increasing the demand for suturing devices. Technological advancements, such as the development of robotic-assisted suturing devices and the incorporation of artificial intelligence (AI), are also contributing to market growth by improving the accuracy and efficiency of surgical procedures. Furthermore, the rising focus on reducing healthcare costs is prompting healthcare providers to seek more effective and affordable surgical solutions, leading to increased adoption of endoluminal suturing devices.

Regionally, North America is expected to dominate the endoluminal suturing device market due to the high healthcare expenditure, well-established healthcare infrastructure, and early adoption of advanced medical technologies. Moreover, the region benefits from a high number of medical device manufacturers and research institutions, fueling innovation. Europe is also a significant market, driven by the increasing number of minimally invasive surgeries and favorable reimbursement policies. Additionally, Europe has a strong healthcare system that supports the integration of new surgical technologies. The Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, primarily due to the growing healthcare infrastructure, rising awareness about advanced surgical techniques, and increasing disposable income in emerging economies, which is enabling more patients to afford these advanced treatments.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Drivers:

Growing Demand for Minimally Invasive Surgeries:

One of the primary drivers of the endoluminal suturing device market is the increasing preference for minimally invasive surgeries. These procedures offer several benefits, including reduced recovery time, less postoperative pain, and minimal scarring, making them more attractive to both patients and healthcare providers. For instance, laparoscopic cholecystectomy typically involves smaller incisions, which reduce the potential for pain, complications, and recovery time. As medical professionals shift toward less invasive methods, endoluminal suturing devices are essential for improving the precision and outcomes of these procedures. This trend is particularly evident in fields such as gastrointestinal and urological surgery, where minimally invasive techniques are becoming the standard.

Aging Population and the Need for Complex Surgeries:

The growing aging population, particularly in developed countries, is another significant factor driving the demand for endoluminal suturing devices. Older individuals are more prone to chronic conditions that require surgical intervention, such as gastrointestinal disorders, cancers, and cardiovascular diseases. For instance, many elderly patients suffering from gastrointestinal disorders benefit from minimally invasive procedures that require the use of suturing devices such as the Eagle Claw VII™ Flexible Endoscopic Suturing System by Olympus Corporation. As the elderly population continues to rise, the demand for effective, minimally invasive surgical solutions will increase, driving the growth of the market for suturing devices that facilitate these complex procedures.

Technological Advancements in Surgical Equipment:

Technological innovations play a crucial role in the expansion of the endoluminal suturing device market. The development of robotic-assisted suturing systems and the integration of artificial intelligence (AI) into surgical procedures have improved accuracy, efficiency, and patient outcomes. For instance, the da Vinci system enables surgeons to perform intricate procedures with enhanced precision, thus reducing the risk of complications. These advancements enable more precise suturing during endoluminal surgeries, reducing complications and improving surgical outcomes. As these technologies become more widely adopted, the market for advanced suturing devices is expected to grow significantly.

Focus on Cost-Effective Healthcare Solutions:

Rising healthcare costs have driven the demand for more affordable and efficient surgical solutions. Endoluminal suturing devices address this need by providing a cost-effective method for conducting complex surgeries with reduced complication rates. For instance, the Endo Stitch™ Suturing Device by Medtronic helps reduce the length of hospital stays, leading to lower overall healthcare costs. This cost-efficiency, combined with the benefits of improved outcomes and faster recovery times, has led healthcare providers to increasingly adopt these devices in their procedures.

Market Trends:

Integration of Robotic-Assisted Technology:

One of the most prominent trends in the endoluminal suturing device market is the integration of robotic-assisted technology. Robotic systems enhance the precision and dexterity of surgeons during endoluminal procedures, allowing for better suturing in hard-to-reach areas. For instance, the da Vinci Surgical System by Intuitive Surgical enhances the precision and control of surgeons, enabling minimally invasive surgeries to be performed with greater accuracy, improving patient outcomes and reducing complications.  As robotic technology becomes more refined and affordable, its adoption is expected to drive market growth, providing surgeons with advanced tools to conduct complex procedures more efficiently.

Adoption of Artificial Intelligence (AI) in Surgical Procedures:

The incorporation of artificial intelligence (AI) into endoluminal suturing devices is another emerging trend. AI-powered devices can assist in the planning and execution of suturing during surgeries, improving precision and reducing human error. For instance, AI algorithms developed by companies like Verb Surgical (a collaboration between Johnson & Johnson and Google) can analyze patient data to provide real-time feedback, enabling surgeons to make more informed decisions. As AI becomes more integrated into surgical devices, the endoluminal suturing market is expected to witness significant advancements in terms of both surgical outcomes and operational efficiency.

Shift Toward Single-Use Devices:

A growing trend in the endoluminal suturing device market is the shift toward single-use devices. Single-use devices offer several advantages, including reduced risk of infection, lower operational costs, and improved convenience for healthcare providers. For instance, the Endo Stitch™ Suturing Device by Medtronic is designed for single use, which helps reduce the risk of infection and eliminates the need for costly sterilization processes. These devices also help reduce the need for costly sterilization processes, making them a more economical choice for hospitals and surgical centers. The increasing preference for single-use endoluminal suturing devices is expected to support the market’s expansion.

Rising Focus on Minimally Invasive Surgery Training:

As the demand for minimally invasive surgeries continues to rise, there is a growing emphasis on training surgeons to use advanced suturing technologies effectively. Medical institutions and hospitals are increasingly incorporating specialized training programs for endoluminal suturing, ensuring that healthcare providers can leverage these advanced tools to improve surgical outcomes. For instance, the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) offers comprehensive training programs for minimally invasive surgical techniques, including endoluminal suturing. This trend is contributing to the overall market growth as it enhances the adoption and utilization of endoluminal suturing devices.

Market Challenges Analysis:

High Cost of Advanced Technologies:

One of the primary challenges in the endoluminal suturing device market is the high cost of advanced technologies, particularly robotic-assisted and AI-powered devices. The high initial investment required for these sophisticated systems can be a significant barrier for smaller healthcare providers and hospitals, particularly in emerging markets with limited budgets. Additionally, the ongoing maintenance and operational costs of such systems can further strain financial resources, limiting their adoption and hindering market growth. While these technologies offer significant improvements in surgical outcomes, the cost remains a key obstacle to their widespread use.

Lack of Skilled Professionals:

Another challenge facing the endoluminal suturing device market is the shortage of skilled professionals who are proficient in using advanced suturing devices. The successful implementation of these devices, especially robotic and AI-assisted systems, requires highly specialized training and expertise. The demand for such trained professionals often exceeds the supply, creating a skills gap in the healthcare industry. This shortage can delay the adoption of new technologies, as healthcare providers may hesitate to invest in devices without having access to qualified personnel to operate them effectively.

Regulatory and Approval Hurdles:

The regulatory landscape presents another challenge for the endoluminal suturing device market. The approval process for medical devices can be time-consuming and costly, with stringent requirements for safety, efficacy, and quality. These regulatory hurdles may delay the introduction of new products to the market, limiting the pace of innovation and growth. Manufacturers must also ensure compliance with different regional regulations, which can complicate the market entry process, especially for global players seeking to expand their reach.

Competition from Alternative Solutions:

Lastly, the presence of alternative surgical techniques, such as traditional suturing methods and other advanced wound closure devices, poses competition to the endoluminal suturing device market. Despite the advantages offered by endoluminal suturing devices, many healthcare providers continue to rely on established methods due to familiarity, lower costs, and perceived ease of use. This competition may slow the adoption of newer, more advanced technologies in certain healthcare settings.

Market Segmentation Analysis:

By Product

The endoluminal suturing device market can be segmented based on product type into manual and robotic-assisted suturing devices. Manual devices, which are more traditional, remain widely used due to their lower cost and familiarity in surgical settings. However, robotic-assisted suturing devices are gaining significant traction due to their precision, enhanced control, and ability to perform complex procedures with minimal invasiveness. As technology advances, the demand for robotic-assisted devices is expected to increase, especially in high-end medical facilities.

By Application

In terms of application, the endoluminal suturing device market is divided into gastrointestinal, thoracic, and urological surgeries. Gastrointestinal surgeries account for the largest share, driven by the rising prevalence of digestive disorders and the increasing preference for minimally invasive procedures. Urological and thoracic surgeries are also experiencing growth, with advancements in surgical techniques and technologies facilitating the use of endoluminal suturing devices in these specialized fields.

By End-User

The end-user segment includes hospitals, surgical centers, and academic and research institutes. Hospitals dominate the end-user segment due to their high patient volume and the need for advanced surgical technologies. Surgical centers are also adopting endoluminal suturing devices at an increasing rate due to their focus on specialized and outpatient procedures. Academic and research institutes contribute to market growth by focusing on the development of new technologies and providing education on their application in surgical settings.

Segmentations:

By Product:

  • Endovascular Suturing Devices
  • Endoscopic Suturing Devices
  • Consumables

By Application:

  • Urological Procedures
  • Thoracic Procedures
  • Gastrointestinal Procedures
  • Other Procedures

By End User:

  • Specialty Clinics
  • Independent Surgical Centers
  • Hospitals
  • Ambulatory Surgical Centers

By Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Regional Analysis:

North America

North America dominates the endoluminal suturing device market, holding a market share of 40%. The region benefits from a highly advanced healthcare infrastructure, substantial healthcare expenditure, and early adoption of innovative technologies, particularly in the United States. The demand for robotic-assisted and AI-powered suturing devices is strong, driven by well-established manufacturers, research institutions, and favorable reimbursement policies. The increasing prevalence of chronic conditions such as gastrointestinal diseases and cancer further supports the growth of this market, along with ongoing technological advancements that continue to drive innovation and adoption.

Europe

Europe holds a 30% market share in the endoluminal suturing device market. The region benefits from a robust healthcare system and many countries offering favorable reimbursement policies for minimally invasive procedures. The increasing number of surgical centers and the preference for minimally invasive surgeries are key factors driving the adoption of endoluminal suturing devices. Countries like Germany, the United Kingdom, and France are particularly seeing high demand for these devices due to their advanced healthcare infrastructure and focus on innovative surgical techniques. Awareness of advanced technologies further contributes to the region’s market growth.

Asia Pacific

The Asia Pacific region is growing the fastest, holding a 20% market share in the endoluminal suturing device market. The region’s rapid growth is driven by improving healthcare infrastructure, rising disposable income, and increased awareness of minimally invasive surgical techniques. Emerging economies like China and India are experiencing a surge in the adoption of advanced medical technologies, including endoluminal suturing devices. The growing prevalence of chronic diseases and an expanding middle class are contributing to the market’s growth. As healthcare systems in these countries continue to modernize, Asia Pacific’s influence in the global market is expected to increase significantly.

Rest of the World (RoW)

The Rest of the World (RoW) region, which includes Latin America, the Middle East, and Africa, accounts for 10% of the global market share. The growth in this region is driven by gradual adoption of advanced medical technologies and rising investments in healthcare infrastructure. However, challenges such as limited access to healthcare resources and lower healthcare expenditure in some areas restrict widespread adoption. Despite these challenges, awareness of minimally invasive surgeries and increasing medical procedures contribute to the steady growth of the market in this region.

Key Player Analysis:

  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Intuitive Surgical, Inc.
  • Zimmer Biomet
  • Boston Scientific Corporation
  • Apollo Endosurgery, Inc.
  • Medline Industries, Inc.
  • ConMed Corporation
  • KARL STORZ SE & Co. KG

Competitive Analysis:

The endoluminal suturing device market is highly competitive, with several key players striving to enhance their market position through product innovation, strategic partnerships, and geographic expansion. For instance, leading companies like Medtronic, Johnson & Johnson, and Intuitive Surgical dominate the market due to their robust portfolios, advanced technologies, and strong distribution networks. Medtronic and Johnson & Johnson focus on expanding their robotic-assisted and AI-powered suturing solutions, driving the adoption of advanced technologies in minimally invasive surgeries. Smaller companies such as Apollo Endosurgery and ConMed emphasize niche applications, particularly in gastrointestinal and bariatric surgeries, offering specialized devices to cater to specific market needs. Additionally, players are increasingly investing in research and development to introduce next-generation suturing devices with enhanced precision, better surgical outcomes, and greater affordability. The market also sees competition based on pricing strategies, with companies focusing on cost-effective solutions to appeal to healthcare providers in emerging economies. As the demand for minimally invasive procedures grows, competition within the market is expected to intensify.

Recent Developments:

  1. In 2024, Medtronic plc continues to focus on advancing surgical techniques through continuous research and development, aiming to support healthcare providers in delivering high-quality care with their endoluminal suturing devices.
  2. In 2024, Ethicon Endo Surgery, a subsidiary of Johnson & Johnson, specializes in developing advanced technologies that enhance the efficacy and safety of minimally invasive procedures. Their extensive portfolio includes a range of endoluminal suturing devices widely used in bariatric surgery and colorectal procedures.
  3. In 2024, Intuitive Surgical, Inc. reported placing 1,526 da Vinci surgical systems, of which 362 were da Vinci 5 systems, marking an 11% increase compared to the previous year.

Market Concentration & Characteristics:

The endoluminal suturing device market is moderately concentrated, with a few dominant players holding significant market share, such as Medtronic, Johnson & Johnson, and Intuitive Surgical. These leading companies have a strong presence globally, supported by extensive product portfolios, advanced technologies, and established distribution networks. The market is characterized by ongoing innovation, with major players investing heavily in research and development to introduce robotic-assisted and AI-powered suturing systems, which are driving growth in minimally invasive surgeries. While large companies maintain a dominant position, smaller players like Apollo Endosurgery and ConMed are carving out niches by offering specialized solutions tailored to specific surgical applications, such as gastrointestinal and bariatric surgeries. Competitive dynamics are further influenced by pricing strategies, technological advancements, and expanding healthcare infrastructure, particularly in emerging economies, which presents both opportunities and challenges for market participants.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Report Coverage:

The research report offers an in-depth analysis based on Product, Application, End-User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

  1. Increasing demand for minimally invasive surgeries will continue to drive growth in the endoluminal suturing device market.
  2. Technological advancements, such as the integration of robotic-assisted systems and AI, will enhance the precision and efficiency of endoluminal suturing procedures.
  3. Rising healthcare expenditure and the adoption of advanced medical technologies, particularly in developed regions, will further fuel market expansion.
  4. The growing aging population, particularly in developed countries, will increase the demand for complex surgeries, further driving the need for endoluminal suturing devices.
  5. The Asia Pacific region will experience rapid market growth due to expanding healthcare infrastructure and increasing awareness of advanced surgical techniques.
  6. Cost-effectiveness and the focus on reducing healthcare expenditures will encourage the adoption of more affordable, high-quality suturing devices.
  7. Regulatory support for minimally invasive procedures and favorable reimbursement policies will continue to promote the use of advanced suturing technologies.
  8. The shift towards single-use endoluminal suturing devices will drive innovation and adoption due to their convenience and reduced risk of infection.
  9. Competition in the market will intensify as smaller players focus on specialized applications and emerging technologies.
  10. Continuous improvements in training and education for healthcare professionals will accelerate the adoption of advanced suturing devices in surgical practice.

For Table OF Content – Request For Sample Report –

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Frequently Asked Questions:

What is the projected growth of the Endoluminal Suturing Device Market?

The market is projected to grow from USD 106.9 million in 2024 to USD 274.28 million by 2032, at a CAGR of 12.5%.

What are the main drivers of market growth?

The growth is driven by the increasing demand for minimally invasive surgeries, technological advancements like robotic and AI-assisted devices, the aging population, and a focus on reducing healthcare costs.

Which regions are leading the market?

North America is expected to dominate due to its healthcare infrastructure and technological advancements. Europe is also significant, while the Asia Pacific region is projected to experience the highest growth rate.

How do technological advancements impact the market?

Technological advancements, such as robotic-assisted suturing and AI integration, improve the accuracy and efficiency of surgeries, contributing to market growth.

Why are minimally invasive surgeries becoming more popular?

Minimally invasive surgeries offer benefits like reduced recovery times, less pain, and minimal scarring compared to traditional approaches, making them increasingly preferred by both patients and healthcare providers.

Cardiology Information System Market

Published:
Report ID: 73891

Carcinoid Tumor Syndrome Management Market

Published:
Report ID: 73881

Canine Dilated Cardiomyopathy Drugs Market

Published:
Report ID: 73871

Brain Metastasis Therapeutics Market

Published:
Report ID: 73846

Bipolar Disorder Drugs and Treatment Market

Published:
Report ID: 73821

Cell & Gene Therapy Clinical Trials Market

Published:
Report ID: 21604

Removable Partial Dentures Market

Published:
Report ID: 73616

Posture Corrector Products Market

Published:
Report ID: 73600

Oncology-Based In Vivo CRO Market

Published:
Report ID: 73597

IVD Contract Manufacturing Market

Published:
Report ID: 73572

Fluoropolymers In Healthcare Market

Published:
Report ID: 73511

Faecal Calprotectin Testing Market

Published:
Report ID: 73373

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$7699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN